Abstract
This chapter discusses techniques for intracranial angioplasty and stenting for atherosclerotic arterial stenosis, and angioplasty and intra-arterial drug infusion for cerebral vasospasm after aneurysmal SAH. Position Statement on Intracranial Angioplasty and Stenting for Cerebral Atherosclerosis by the ASITN, SIR, and ASNR: (1) For symptomatic patients with >50% intracranial stenosis who have failed medical therapy, balloon angioplasty with or without stenting should be considered; (2) Patients who have an asymptomatic intracranial arterial stenosis should first be counseled regarding optimizing medical therapy. There is insufficient evidence to make definite recommendations regarding endovascular therapy in asymptomatic patients with severe intracranial atherosclerosis. They should be counseled regarding the nature and extent of their disease, monitored for new neurological symptoms, and have periodic noninvasive imaging at regular intervals of 6–12 months (MRA or CTA) initially, and later with cerebral angiography if warranted. Optimal prophylactic medical therapy should be instituted, which might include antiplatelet and/or statin therapy; and (3) Continued evaluation and improvements in both pharmacological and catheter-based therapies are needed to reduce the possibility of stroke from intracranial atherosclerosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
ASITN, American Society of Interventional and Therapeutic Neuroradiology; SIR, Society of Interventional Radiology; and ASNR, American Society of Neuroradiology.
References
Higashida RT, Meyers PM, Connors III JJ, Sacks D, Strother CM, Barr JD, Wojak JC, Duckwiler GR. Intracranial angioplasty and stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2005;26:2323–7.
Abou-Chebl A, Krieger DW, Bajzer CT, Yadav JS. Intracranial angioplasty and stenting in the awake patient. J Neuroimaging. 2006;16:216–23.
Kiyosue H, Okahara M, Yamashita M, Nagatomi H, Nakamura N, Mori H. Endovascular stenting for restenosis of the intracranial vertebrobasilar artery after balloon angioplasty: two case reports and review of the literature. Cardiovasc Intervent Radiol. 2004;27:538–43.
Kessler IM, Mounayer C, Piotin M, Spelle L, Vanzin JR, Moret J. The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol. 2005;26:2342–8.
Stryker Neurovasular. Wingspan Stent System with Gateway PTA Balloon Product Prescriptive Information. Instructions for Use. Fremont, CA 2012.
Hansi C, Arab A, Rzany A, Ahrens I, Bode C, Hehrlein C. Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces. Catheter Cardiovasc Interv. 2009;73:488–96.
Schmehl JM, Harder C, Wendel HP, Claussen CD, Tepe G. Silicon carbide coating of nitinol stents to increase antithrombogenic properties and reduce nickel release. Cardiovasc Revasc Med. 2008;9:255–62.
Bickel C, Rupprecht HJ, Darius H, et al. Substantial reduction of platelet adhesion by heparin-coated stents. J Interv Cardiol. 2001;14:407–13.
Monnink SH, van Boven AJ, Peels HO, et al. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. J Investig Med. 1999;47:304–10.
Dahm JB, Willems T, Wolpers HG, Nordbeck H, Becker J, Ruppert J. Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation). EuroIntervention. 2009;4:502–8.
Bolz A, Brem B, Schaldach M. Corrosion behavior of antithrombogenic coating of silicon carbide. Biomed Tech (Berl). 1990;35 Suppl 2:227–9.
Coolong A, Mauri L. Clopidogrel treatment surrounding percutaneous coronary intervention: when should it be started and stopped? Curr Cardiol Rep. 2006;8:267–71.
Qureshi AI, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916–9.
Macdonald RL. Management of cerebral vasospasm. Neurosurgical Review 2006;29:179–93.
Harrigan MR. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm. Crit Care. 2010;14:151.
Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery. 1999;44:975–9; discussion 979–80.
Jabbour P, Veznedaroglu E, Liebman K, Rosenwasser RH. Is radiographic ischemia a contraindication for angioplasty in subarachnoid hemorrhage? In: AANS annual meeting. San Francisco: American Association of Neurological Surgeons; 2006.
American Society of Interventional and Therapeutic Neuroradiology. Mechanical and pharmocologic treatment of vasospasm. AJNR Am J Neuroradiol. 2001;22:26S–7S.
Bernardini GL, Mayer SA, Kossoff SB, Hacein-Bey L, Solomon RA, Pile-Spellman J. Anticoagulation and induced hypertension after endovascular treatment for ruptured intracranial aneurysms. Crit Care Med. 2001;29:641–4.
Hoh BL, Nogueira RG, Ledezma CJ, Pryor JC, Ogilvy CS. Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement. Neurosurgery. 2005;57:845–9; discussion 845–9.
Raabe A, Gerlach R, Zimmermann M, Seifert V. The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien). 2001;143:1–7.
Terry A, Zipfel G, Milner E, et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus. 2006;21:E14.
Eskridge JM, Song JK. A practical approach to the treatment of vasospasm. AJNR Am J Neuroradiol. 1997;18:1653–60.
Murayama Y, Song JK, Uda K, et al. Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm. AJNR Am J Neuroradiol. 2003;24:133–9.
ev3 Neurovascular/Covidien. Hyperform Balloon. Instructions for Use. Irvine, CA 2012.
Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am. 2005;16:501–16; vi.
Sayama CM, Liu JK, Couldwell WT. Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurosurg Focus. 2006;21:E12.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Harrigan, M.R., Deveikis, J.P. (2013). Endovascular Treatment of Intracranial Stenosis and Vasospasm. In: Handbook of Cerebrovascular Disease and Neurointerventional Technique. Contemporary Medical Imaging, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-946-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-946-4_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-945-7
Online ISBN: 978-1-61779-946-4
eBook Packages: MedicineMedicine (R0)